Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPM
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
A majority of Korean doctors tend to add other antihypertensive rather than to titrate the
same drug.
However, we try to induce doctors to titrate the Sevikar than to add other antihypertensive
if patients are not controlled with Sevikar 5/20mg(amlodipine 5mg + omlesartan 20mg). As
above, for patients who are not controlled with Sevikar 5/20mg, doctors will proceed to other
prescription pattern with other choices of titration to Sevikar 5/40, 10/40mg.
It is important to evaluate BP lowering efficacy of Sevikar through the titration step in
patients uncontrolled with Sevikar low dose. Thus, this study is designed to demonstrate the
efficacy of Sevikar by titration in patients who are not controlled their BP with low dose of
Sevikar.
Phase:
Phase 4
Details
Lead Sponsor:
Sang Hyun Ihm, MD PhD
Collaborators:
Daewoong Pharmaceutical Co. LTD. Daiichi Sankyo Korea Co., Ltd.